ATLANTA, June 02, 2022 (GLOBE NEWSWIRE) -- Alimera Sciences, Inc. (Nasdaq: ALIM) (“Alimera”), a global pharmaceutical company whose mission is to be invaluable to patients, physicians, and partners concerned with retinal health and maintaining better vision longer, announced today that Rick Eiswirth, Alimera’s President and Chief Executive Officer, will present a corporate overview at the LD Micro Invitational XII Conference. The conference is being held on June 7 – 9, 2022 at the Four Seasons in Westlake Village, CA.
| Presentation Date: | June 7, 2022 | |
| Time: | 9:30am (PDT) | |
| Webcast Link: | LDinv12.mysequire.com |
Mr. Eiswirth will be available for one-on-one meetings with registered attendees of the conference.
About Alimera
Alimera is a global pharmaceutical company whose mission is to be invaluable to patients, physicians, and partners concerned with retinal health and maintaining better vision longer. For more information, please visit www.alimerasciences.com.
| For press inquiries: Cindy Rizzo for Alimera ir@alimerasciences.com | For investor inquiries: Scott Gordon for Alimera scottg@coreir.com |
